We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
EMSOL is a collaborated, passionate, expert, professional business and local authority. It intelligently focuses on air pollution that needs to be urgently reduced. The company provides an IoT platform and sensor-based service to unlock environmental insights that enable permanent, feasible, and rapid change. EMSOL measures air and noise pollution by using the latest calibrated sensors with its clever mathematics it targets interventions to reduce pollution. The company's team is a range of committed, top-quality domain experts. The company is already working with fleet operators, local councils, and developers by generating data-led insights to act on the causes of transport pollution.
days to go: Expired investment: Withheld
A FCA-regulated digital bond marketplace offering investors high yield and senior secured bonds and loans in market-leading businesses. The WiseAlpha platform includes financial opportunities in companies such as Santander, Virgin Media, McLaren and EDF, amongst many other large brands. There are more than 4,000 members signed up to WiseAlpha, which offers interest returns between 3% and 15%. At the British Banking Awards 2018, WiseAlpha was the winner of the Best Investments Provider Award and the company has been featured in many publications, including Bloomberg, The Financial Times, Moneyweek and City AM. WiseAlpha members can invest via depositing money from their bank account, or using their SIPP account. The company have also recently beta-launched 'Robowise', an automatic investment tool that will diversify a member's portfolio for them. Funds are being raised for WiseAlpha to grow and expand the business. The company intends to enter into the European investment market, further develop their 'Robowise' tool and offer more products such as ISAs.
days to go: Expired investment: £2,813,650
Gendius' has created intellin, an application through which people can track diabetes and make a good decision to reduce the risk of diabetes. It is on a mission to make sure that every person with diabetes knows their risk of complications and how to control them. The company has been launched across the EU with over 3,500 downloads in the EU and UK. In 2018, the company won £25K Momentum award to complete UX/UI research and, it has passed ISO27001. Recently, it has been invited to HIMSSHealth2.0 conference for the application's live demo.
days to go: Expired investment: £518,630
Rnwl is aiming to be the first ever over-the-top insurance platform. The company asserts that conventional insurance companies rely on a lead generation business model that is archaic and inefficient. These result in a customer's insurance options becoming an expensive and time-consuming affair. Rnwl is endeavouring to simplify this. Users can enter their credentials and requirements on the Rnwl website. The company will analyse the market and suggest the best deals for the user. Rnwl has been accepted into the Financial Conduct Authority (FCA's) Innovation Hub. It will use 74% of the investment in human resource, 14% in marketing, and 12% as operational costs.

Pitch Rated

45%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £450,366
Tech Will Save Us is a company that specialises in making STEAM (Science, Technology, Engineering, Art, and Math) kits for children in the 4-6, 7-10 and 11+ age categories. The company has created a home learning system that enables kids to learn about the world through technology and play. There are three core components to its home learning system: A Digital platform, Physical Experiences and Subscriptions through which the company has helped over 1 million kids build & create. For its ingenuity, the company received the 2019 Good Housekeeping Best Toy Award for Electro Guitar and the Design of the Year Nomination by the London Design Museum. It also collaborated with the BBC to develop The BBC micro: bit., a pocket-sized computer designed for kids to invent with which, in turn, was given to one million kids and is now used in over 40 countries. Its first coding product, Gamer Kit was launched at WIRED's 1st Next Gen conference amidst positive feedback. The company will use 15% of the proceeds in Technology and Research & Development, 25% for marketing, and 60% for working capital and team building.
days to go: Expired investment: £843,940
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph